BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 16789422)

  • 1. [Serum amyloid A (SAA)--pathogenicity and implication of appearance in plasma].
    Yamada T
    Rinsho Byori; 2006 May; 54(5):509-12. PubMed ID: 16789422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is the serum amyloid A protein in acute phase plasma high density lipoprotein the precursor of AA amyloid fibrils?
    Baltz ML; Rowe IF; Caspi D; Turnell WG; Pepys MB
    Clin Exp Immunol; 1986 Dec; 66(3):701-8. PubMed ID: 3105937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Syrian and Armenian hamsters differ in serum amyloid A gene expression. Identification of novel Syrian hamster serum amyloid A subtypes.
    de Beer MC; de Beer FC; Beach CM; Gonnerman WA; Carreras I; Sipe JD
    J Immunol; 1993 Jun; 150(12):5361-70. PubMed ID: 8515064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Inflammatory reaction and laboratory tests: serum amyloid A (SAA) protein].
    Yamada T
    Rinsho Byori; 1990 Mar; 38(3):249-54. PubMed ID: 2112209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential expression of the amyloid SAA 3 gene in liver and peritoneal macrophages of mice undergoing dissimilar inflammatory episodes.
    Rokita H; Shirahama T; Cohen AS; Meek RL; Benditt EP; Sipe JD
    J Immunol; 1987 Dec; 139(11):3849-53. PubMed ID: 3680951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum amyloid A serum concentrations and genotype do not explain low incidence of amyloidosis in Hyper-IgD syndrome.
    van der Hilst JC; Drenth JP; Bodar EJ; Bijzet J; van der Meer JW; Simon A;
    Amyloid; 2005 Jun; 12(2):115-9. PubMed ID: 16011988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular and cellular biology of serum amyloid A.
    Rienhoff HY; Huang JH; Li XX; Liao WS
    Mol Biol Med; 1990 Jun; 7(3):287-98. PubMed ID: 2170811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of Serum Amyloid A (SAA1) and SAA2 gene polymorphisms on renal amyloidosis, and on SAA/C-reactive protein values in patients with familial mediterranean fever in the Turkish population.
    Bakkaloglu A; Duzova A; Ozen S; Balci B; Besbas N; Topaloglu R; Ozaltin F; Yilmaz E
    J Rheumatol; 2004 Jun; 31(6):1139-42. PubMed ID: 15170927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum amyloid A3 (SAA3), not SAA1 appears to be the major acute phase SAA isoform in the pig.
    Soler L; Luyten T; Stinckens A; Buys N; CerĂ³n JJ; Niewold TA
    Vet Immunol Immunopathol; 2011 May; 141(1-2):109-15. PubMed ID: 21439655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular events associated with the initial phase of AA amyloidogenesis: insights from a human monocyte model.
    Magy N; Benson MD; Liepnieks JJ; Kluve-Beckerman B
    Amyloid; 2007 Mar; 14(1):51-63. PubMed ID: 17453625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue-specific regulation of the human acute-phase serum amyloid A genes, SAA1 and SAA2, by glucocorticoids in hepatic and epithelial cells.
    Thorn CF; Lu ZY; Whitehead AS
    Eur J Immunol; 2003 Sep; 33(9):2630-9. PubMed ID: 12938239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [No significant influence of serum amyloid A1 genotypes on serum lipids or HDL clearance].
    Wada A; Yamada T; Itoh K; Igari J
    Rinsho Byori; 2000 Feb; 48(2):174-7. PubMed ID: 10804822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum amyloid protein SAA, C-reactive protein and lysozyme in leprosy.
    Scheinberg MA; Masuda A; Benson MD; Mendes NF
    Int J Lepr Other Mycobact Dis; 1979 Jun; 47(2):133-7. PubMed ID: 572349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical value of serum amyloid A and C-reactive protein measurements in secondary amyloidosis.
    Maury CP; Wegelius O
    Int J Tissue React; 1985; 7(5):405-7. PubMed ID: 4055265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Serum amyloid A protein--a general acute phase reactant].
    Janousek J
    Cas Lek Cesk; 1990 Nov; 129(47):1484-7. PubMed ID: 2257593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation and use of site-specific antibodies to serum amyloid A for probing amyloid A development.
    Miura K; Ju ST; Cohen AS; Shirahama T
    J Immunol; 1990 Jan; 144(2):610-3. PubMed ID: 2295803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased susceptibility of serum amyloid A 1.1 to degradation by MMP-1: potential explanation for higher risk of type AA amyloidosis.
    van der Hilst JC; Yamada T; Op den Camp HJ; van der Meer JW; Drenth JP; Simon A
    Rheumatology (Oxford); 2008 Nov; 47(11):1651-4. PubMed ID: 18815155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased circulating serum amyloid A protein derivatives in rheumatoid arthritis patients with secondary amyloidosis.
    Migita K; Eguchi K; Tsukada T; Kawabe Y; Takashima H; Mine M; Aoyagi T; Ichinose Y; Nagataki S
    Lab Invest; 1996 Sep; 75(3):371-5. PubMed ID: 8804360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Inflammatory markers; C-reactive protein (CRP) and serum amyloid A (SAA)].
    Yamada T
    Rinsho Byori; 2005 Jun; 53(6):558-61. PubMed ID: 16026085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transformation from SAA2-fibrils to AA-fibrils in amyloid fibrillogenesis: in vivo observations in murine spleen using anti-SAA and anti-AA antibodies.
    Arai K; Miura K; Baba S; Shirasawa H
    J Pathol; 1994 Jun; 173(2):127-34. PubMed ID: 8089807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.